Literature DB >> 486134

Ability of human chorionic gonadotropin beta-subunit to inhibit the steroidogenic response to lutropin.

R R Dighe, K Muralidhar, N R Moudgal.   

Abstract

Ability of the beta-subunit of human chorionic gonadotropin to inhibit the response to lutropin (luteinizing hormone, LH) was tested in the immature rat ovarian system and pregnant-mare-serum-gonadotropin-primed rat ovarian system with progesterone production being used as the response. Human chorionic gonadotropin beta-subunit was found to inhibit human and ovine lutropin-stimulated progesterone production. At a constant dose of lutropin, inhibition was dependent on the concentration of beta-subunit. When concentration of the beta-subunit was kept constant at 5.0 microgram/ml and the concentration of lutropin was varied, the inhibition was maximum at the saturating concentration of the native hormone. The alpha-subunit of the human chorionic gonadotropin did not inhibit the response to lutropin. The lutropin/beta-subunit ratio required to produce an inhibition of response was much lower than that required to bring about an observable inhibition of binding.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 486134      PMCID: PMC1161096          DOI: 10.1042/bj1800573

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  10 in total

1.  Comparison of the binding of human chorionic gonadotropin to isolated bovine luteal cells and bovine luteal plasma membranes.

Authors:  S Papaionannou; D Gospodarowicz
Journal:  Endocrinology       Date:  1975-07       Impact factor: 4.736

2.  Studies on rat ovarian receptors for lutropin (luteinizing hormone). Applicability of radioimmunoassay to measure lutropin bound to receptors.

Authors:  K Muralidhar; N R Moudgal
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

3.  Stimulation of ovarian cyclic guanosine 3',5'-monophosphate levels by the subunits of human chorionic gonadotropin.

Authors:  C V Rao; F Carman
Journal:  Biochem Biophys Res Commun       Date:  1973-09-18       Impact factor: 3.575

4.  Properties of the subunits of human chorionic gonadotropin.

Authors:  F J Morgan; R E Canfield; J L Vaitukaitis; G T Ross
Journal:  Endocrinology       Date:  1974-06       Impact factor: 4.736

5.  The effect of ICSH- and its combination with prolactin on the maintenance of pregnancy in the rat.

Authors:  W H Yang; M R Sairam; C H Li
Journal:  Acta Endocrinol (Copenh)       Date:  1973-01

6.  Absence of intrinsic biological activity in LH and hCG subunits.

Authors:  K J Catt; M L Dufau; T Tsuruhara
Journal:  J Clin Endocrinol Metab       Date:  1973-01       Impact factor: 5.958

7.  Ovulation in hamster: induction by subunit of ovine interstitial cell stimulating hormone.

Authors:  W H Yang; M R Sairam; H Papkoff; C H Li
Journal:  Science       Date:  1972-02-11       Impact factor: 47.728

8.  Studies on luteolysis: effect of antiserum to luteinizing hormone on sterols and steroid levels in pregnant hamsters.

Authors:  V Mukku; N R Moudgal
Journal:  Endocrinology       Date:  1975-12       Impact factor: 4.736

9.  Studies on rat ovarian receptors for lutropin (luteinizing hormone). Factors influencing binding and response.

Authors:  K Muralidhar; N R Moudgal
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

10.  Studies on rat ovarian receptors for lutropin (luteinizing hormone). Interaction with beta-subunit of sheep lutropin.

Authors:  K Muralidhar; N R Moudgal
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

  10 in total
  2 in total

1.  Preferential masking by the receptor of immunoreactive sites on the alpha subunit of human choriogonadotropin.

Authors:  R P Milius; A R Midgley; S Birken
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

2.  Beta subunits of human choriogonadotropin and ovine lutropin are biologically active.

Authors:  N R Moudgal; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.